Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Catalyst Bio Cmn (NASDAQ: CBIO)

$4.02 USD $0.03 (0.75%)
Last Price $4.02
Net Change $0.03 (0.75%)
Bid $3.99
Ask Price $4.02
Open Price $3.95
Previous Close Price $3.99
High Price $4.02
Low Price $3.94
Number of Trades 51
Volume 44,845
Fifty Two Week High $50.7 (2016-06-10)
Fifty Two Week Low $3.64 (2017-05-15)
Average Daily Volume 577,849
Share Outstanding 4,260 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $11.77
Recent Earnings $
Annual EPS $-21.55
Last Quarter EPS $
Market Capitalization $0.02B
Insider Shareholders % 0.05%
Annual Revenue $0B
No. Shares Outstanding 4,260
Inst. Shareholder % 21.08%
Annual Net Income $-0.02B
TTM Net Profit Margin $-3123.21
1-Year Return -83.38%
3-Year Return -98.63%
5-Year Return -98.77%
5-Year Revenue Growth -99.59%
5-Year Earnings Growth -23.23%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 11.77%
Dividends per Share $0.569
Stock Split Ratio 1-15
Beta 1.64
Catalyst Biosciences, Inc. is a biopharmaceutical company which focused on creating and developing medicines to address serious medical conditions. The Company's hemostasis product candidates include CB 813d/PF-0520602, CB 2679d/ISU 304 and FXa. Anti-Complement Product consists of CB 2782 and Ophthalmic which are in clinical different trail. Catalyst Biosciences, Inc., formerly known as Targacept, Inc., is based in South San Francisco, Calif.

No News found for CBIO